Myseum.AI Inc. MYSE
1.86
0.00
0.00%
as of 25 Sep
- Market cap
- $9.6M
- P/E
- 0.0×
Follow MYSE
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
15,902.49 | 11,960.88 | 11,203.78 | 25,102.73 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(9.23) | (9.55) | (5.37) | (8.30) | |
P/B ratio |
1.68 | 1.18 | 1.74 | 2.87 | |
Price to Tangible BV |
2.05 | 1.42 | 2.37 | 3.76 | |
EV/Sales |
7,895.99 | 5,742.71 | 7,256.28 | 17,242.13 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.98) | (0.81) | (1.01) | (1.90) | |
EV/FCF |
(0.91) | (0.74) | (0.93) | (1.75) | |
Quick Ratio |
5.41 | 4.03 | 2.56 | 5.05 | |
Current Ratio |
5.72 | 4.29 | 3.09 | 5.34 | |
Net Debt/EBITDA |
3.83 | 2.40 | 1.42 | 1.84 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | (0.59) | 0.44 | 0.50 | |
Capex/Depreciation |
(7.42) | (0.20) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
426,966.67% | 1,581,400.00% | 1,685,500.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
65,366.67% | 230,900.00% | 389,600.00% | 0.00% | |
Graham Net Nets |
0.42 | 0.40 | 0.27 | 0.26 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(53.54%) | (37.68%) | (60.78%) | (50.57%) | |
Free Cash Flow Yield |
(54.57%) | (64.69%) | (69.96%) | (39.22%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.24) | (0.18) | (0.29) | (0.30) | |
Capex per Share |
(0.05) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.29) | (0.18) | (0.29) | (0.30) | |
Cash per Share |
1.14 | 0.89 | 0.55 | 0.79 | |
Shareholders Equity per Share |
1.35 | 1.45 | 0.90 | 0.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.35 | 1.45 | 0.90 | 0.88 | |
Free Cash Flow |
(1.22) | (0.76) | (1.25) | (1.51) | |
Working Capital |
4.19 | 3.05 | 1.94 | 3.37 | |
Capital Expenditures |
(0.19) | (0.01) | — | — | |
Net Current Asset Value |
4.01 | 2.88 | 1.78 | 3.23 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
636.00 | 55.00 | 0.00 | 0.00 | |
Net Profit Margin |
(400,500.00%) | 1,284,300.00% | (2,861,600.00%) | 0.00% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.65 | 0.74 | 0.79 | 0.66 | |
Average Assets |
5.79 | 6.28 | 6.73 | 6.37 | |
Average Common Equity |
4.99 | 5.42 | 5.84 | 5.49 |
Columns are period end dates